-
5341
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy
Published 2025-08-01“…The clinical relevance of vibostolimab, based on these mechanisms, in combination with pembrolizumab was recently tested in registrational trials.…”
Get full text
Article -
5342
-
5343
A Systematic Review and Meta-analysis of the Association Between ACTN3 R577X Genotypes and Performance in Endurance Versus Power Athletes and Non-athletes
Published 2024-04-01“…Results After screening 476 initial registrations, 25 studies were included in the final analysis (13 different countries; 14,541 participants). …”
Get full text
Article